Evaluating the Bioequivalence of HIP1302, HGP1406

NCT02545829 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: HIP1302
DRUG: HGP1406

Sponsor

Hanmi Pharmaceutical Company Limited